Graduate Program in Health Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil.
Center of Biotechnology, Graduate Program in Cell and Molecular Biology (PPGBCM), Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.
Infect Genet Evol. 2021 Sep;93:104941. doi: 10.1016/j.meegid.2021.104941. Epub 2021 May 25.
The COVID-19 pandemic caused by SARS-CoV-2 has affected millions of people since its beginning in 2019. The propagation of new lineages and the discovery of key mechanisms adopted by the virus to overlap the immune system are central topics for the entire public health policies, research and disease management. Since the second semester of 2020, the mutation E484K has been progressively found in the Brazilian territory, composing different lineages over time. It brought multiple concerns related to the risk of reinfection and the effectiveness of new preventive and treatment strategies due to the possibility of escaping from neutralizing antibodies. To better characterize the current scenario we performed genomic and phylogenetic analyses of the E484K mutated genomes sequenced from Brazilian samples in 2020. From October 2020, more than 40% of the sequenced genomes present the E484K mutation, which was identified in three different lineages (P.1, P.2 and B.1.1.33 - posteriorly renamed as N.9) in four Brazilian regions. We also evaluated the presence of E484K associated mutations and identified selective pressures acting on the spike protein, leading us to some insights about adaptive and purifying selection driving the virus evolution.
自 2019 年 SARS-CoV-2 引发的 COVID-19 大流行以来,已经影响了数百万人。新谱系的传播和病毒采用的关键机制被发现,这是整个公共卫生政策、研究和疾病管理的核心议题。自 2020 年第二学期以来,E484K 突变逐渐在巴西境内被发现,随着时间的推移,形成了不同的谱系。由于可能逃避中和抗体,它带来了与再次感染风险和新的预防及治疗策略的有效性相关的多重担忧。为了更好地描述当前的情况,我们对 2020 年从巴西样本中测序的 E484K 突变基因组进行了基因组和系统发育分析。自 2020 年 10 月以来,超过 40%的测序基因组存在 E484K 突变,该突变在巴西四个地区的三个不同谱系(P.1、P.2 和 B.1.1.33 - 后来更名为 N.9)中被发现。我们还评估了与 E484K 相关的突变的存在情况,并确定了作用于刺突蛋白的选择压力,使我们对驱动病毒进化的适应性和净化选择有了一些了解。